天眼查App显示，近日，广东尚得生物科技有限公司成立，注册资本500万人民币，经营范围为许可项 目：食品生产；食品销售；饲料生产；食品添加剂生产；饲料添加剂生产；食品互联网销售。（依法须 经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为 准）一般项目：生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技术 推广；生物饲料研发；饲料原料销售；饲料添加剂销售；食品添加剂销售；宠物食品及用品批发；宠物 食品及用品零售；农副产品销售；食品销售（仅销售预包装食品）；保健食品（预包装）销售；工业用 动物油脂化学品制造；工业用动物油脂化学品销售；非食用植物油加工；非食用植物油销售；包装材料 及制品销售；初级农产品收购；智能仓储装备销售；普通货物仓储服务（不含危险化学品等需许可审批 的项目）；采购代理服务；销售代理；食品互联网销售（仅销售预包装食品）；互联网销售（除销售需 要许可的商品）；再生资源销售；再生资源回收（除生产性废旧金属）；资源再生利用技术研发。（除 依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Group 1 - Zhengzhou will host three recruitment fairs, providing over 20,000 job positions across various regions, industries, and demographics [1] - The recruitment fairs will feature a combination of job matching, skills training, and unique empowerment activities to create a multi-layered employment service platform for job seekers [1][2] - The first recruitment fair on December 10 will offer more than 8,700 job positions from well-known companies in sectors such as manufacturing, biotechnology, information technology, and food processing [1][2] Group 2 - The recruitment fairs will include special activities like a short drama actor audition and hand-knitting training to enhance the appeal and effectiveness of the events [2] - The second recruitment fair on December 11 will focus on high-level talents and recent graduates, providing over 6,600 job positions in various fields including finance, education, and healthcare [3][4] - The third recruitment fair on December 13 will be held for key enterprises, further expanding job opportunities for job seekers [3][4] Group 3 - The job positions available will cover a wide range of professional categories, including software development, project management, and marketing, totaling over 9,900 positions [4] - The recruitment fairs will feature dedicated areas for company recruitment and displays, along with mobile services for easy resume submission [5]

天眼查App显示，近日，宿州科蔺生物科技有限公司成立，法定代表人为李琼，注册资本30万人民币， 经营范围为许可项目：卫生用品和一次性使用医疗用品生产；食品用洗涤剂生产；建筑劳务分包（依法 须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件 为准）一般项目：生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技 术推广；化工产品生产（不含许可类化工产品）；基础化学原料制造（不含危险化学品等许可类化学品 的制造）；专用化学产品制造（不含危险化学品）；日用化学产品制造；化工产品销售（不含许可类化 工产品）；食品用洗涤剂销售；个人卫生用品销售；日用品销售；专用化学产品销售（不含危险化学 品）；日用化学产品销售；日用百货销售；日用杂品制造；日用杂品销售；消毒剂销售（不含危险化学 品）；专业保洁、清洗、消毒服务；美发饰品销售；卫生用品和一次性使用医疗用品销售；化妆品零 售；办公用品销售（除许可业务外，可自主依法经营法律法规非禁止或限制的项目）。 ...

Core Insights - The European Commission has officially released a new bioeconomy strategy framework, focusing on "competitiveness + sustainability" as dual core objectives aimed at accelerating the circular economy and decarbonization while reducing dependence on imported fossil fuels [1] - The strategy identifies ten core application areas for bio-based materials and technologies, covering end products such as plastics, textiles, and chemicals, as well as key technological directions like biorefining, advanced fermentation, and permanent storage of biochar [1] - The bioeconomy is seen as a crucial pathway for Europe to enhance economic resilience and replace fossil-based products, supporting 17.1 million jobs and positioning Europe to capture a leading role in the global clean industry [1] Industry Developments - The bioeconomy in the EU has reached a scale of €2.7 trillion in 2023, with expanding application scenarios including bio-based chemicals from algae serving the pharmaceutical and daily chemical sectors, and bio-based plastics gradually replacing traditional materials in packaging and automotive parts [1] - The strategy aims to achieve three goals: enhancing resilience, increasing competitiveness, and protecting the ecosystem, with a commitment to ensuring that natural ecology remains the foundation of economic development [1] Implementation Framework - To unlock potential, the EU has established a three-dimensional implementation system of "regulation + funding + market": simplifying regulatory frameworks to incentivize sustainable business models while ensuring safety, guiding EU finances towards bio-based technologies, and setting demand targets through legislation [2] - The establishment of the "European Bio-based Alliance" aims to facilitate collective procurement of €10 billion in bio-based solutions by 2030 [2] - Industry responses have been positive, with calls for a specialized legal framework and market premium mechanisms for low-carbon products, emphasizing the need for stronger policy guidance to accelerate the commercialization of innovative results [2]

Core Viewpoint - The announcement details the completion of the 2025 restricted stock incentive plan by Jiangsu Lanfeng Biological Chemical Co., Ltd, including the number of shares granted, the recipients, and the conditions for vesting and performance assessment [1][19]. Group 1: Stock Grant Details - The number of restricted shares granted is 20.03 million, accounting for 5.63% of the company's total shares before the grant [1][7]. - The grant date for the restricted shares is November 24, 2025, with the shares set to be listed on December 8, 2025 [6][16]. - The grant price for the restricted shares is set at 2.64 yuan per share [7]. Group 2: Recipients and Approval Process - A total of 71 individuals are designated as recipients of the restricted shares, including senior management, middle management, and key employees [2][7]. - The decision-making process involved multiple board meetings and approvals, with legal opinions provided by Beijing Wanshang Tianqin Law Firm [3][5]. Group 3: Vesting Conditions - The vesting period for the restricted shares is set at 12 months and 24 months from the date of grant, during which the shares cannot be transferred or used as collateral [8][9]. - Performance assessment for the vesting of shares will be based on company-level and individual-level criteria over the years 2025 and 2026 [10][12]. Group 4: Financial Impact - The total number of shares after the grant will increase from 355.56 million to 375.59 million, affecting the shareholding structure of major shareholders [17][19]. - The incentive plan is expected to raise approximately 52.88 million yuan, which will be used to supplement working capital [15][17]. Group 5: Compliance and Reporting - The company has confirmed that there were no stock trading activities by participating directors and senior management in the six months prior to the grant [18]. - The company will continue to monitor shareholder equity changes and comply with relevant disclosure obligations [19].

天眼查App显示，近日，石家庄麦朵生物科技有限公司成立，法定代表人为刘建龙，注册资本5万人民 币，经营范围为一般项目：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广;生物化 工产品技术研发;化工产品生产（不含许可类化工产品）;化工产品销售（不含许可类化工产品）;饲料原 料销售;畜牧渔业饲料销售;生物饲料研发;饲料添加剂销售;肥料销售;生物有机肥料研发;化肥销售;农副产 品销售;日用化学产品销售;专用化学产品销售（不含危险化学品）;初级农产品收购;生物基材料销售;机 械设备销售;木材加工;建筑材料销售;五金产品零售;货物进出口（除依法须经批准的项目外，凭营业执 照依法自主开展经营活动）许可项目：饲料生产;饲料添加剂生产;肥料生产（依法须经批准的项目，经 相关部门批准后方可开展经营活动，具体经营项目以批准文件或许可证件为准）。 ...

Core Viewpoint - Harbin Air Conditioning (哈空调) is attempting to divest its underperforming subsidiary, Harbin Fushanchuan Biotechnology Development Co., Ltd. (富山川), to streamline operations amid financial pressures and a need for transformation [1][2] Group 1: Asset Divestiture - The company plans to publicly transfer 40% of its stake in Fushanchuan at a minimum price of 3.8126 million yuan, based on an assessed value [2][3] - Fushanchuan has ceased operations and is currently in a "dormant state," with a reported net loss of 16.0963 million yuan for 2024, which is 218.83% of Harbin Air Conditioning's previous year's net profit [2][3] - The valuation of Fushanchuan shows a 7.69% increase from its book value, with total equity assessed at 9.5314 million yuan [2] Group 2: Financial Challenges - Harbin Air Conditioning's revenue for the first three quarters of 2025 was 827 million yuan, a year-on-year decrease of 12.19%, with a net loss of 23.8215 million yuan [3] - Fushanchuan has been listed as a dishonest executor, with its bank accounts frozen due to legal disputes, and it is involved in multiple contract disputes that have led to additional financial liabilities [4] - The company has an outstanding unfulfilled capital contribution of 15.4718 million yuan related to its investment in Fushanchuan, which poses a financial risk [4][5] Group 3: Internal Financial Obligations - Fushanchuan owes Harbin Air Conditioning approximately 19.7955 million yuan in various internal debts, with no clear repayment plan provided [5] - The other shareholders of Fushanchuan have waived their right of first refusal on the share transfer, necessitating Harbin Air Conditioning to seek external buyers [5] - The company has acknowledged the uncertainty surrounding the success of the transaction and the final terms of the sale [5]

本报讯(记者袁传玺)天眼查工商信息显示，近日，哈尔滨裕诚生物技术有限公司成立，注册资本2000万 元，经营范围含生物化工产品技术研发、发酵过程优化技术研发、化工产品生产、互联网销售等。股东 信息显示，该公司由哈三联（002900）全资持股。 ...

天眼查App显示，近日，山东赛茵特生物科技有限公司成立，法定代表人为丁培杰，注册资本8000万人 民币，经营范围为一般项目：生物化工产品技术研发；生物农药技术研发；化工产品销售（不含许可类 化工产品）；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；技术进出口；货物进 出口。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：农药批发；农药零 售。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件 或许可证件为准）。 ...

天眼查App显示，近日，江西玲隆生物科技有限公司成立，法定代表人为韩文，注册资本3万人民币， 经营范围为一般项目：生物化工产品技术研发，新材料技术研发，新材料技术推广服务，技术服务、技 术开发、技术咨询、技术交流、技术转让、技术推广，非食用植物油销售，传统香料制品经营，日用化 学产品销售，日用杂品销售，化妆品零售，化妆品批发，消毒剂销售（不含危险化学品），日用百货销 售，日用品销售，日用品批发，食品添加剂销售，专用化学产品销售（不含危险化学品），农副产品销 售，初级农产品收购，中草药收购，树木种植经营，个人卫生用品销售，香料作物种植，饲料添加剂销 售，化工产品销售（不含许可类化工产品），货物进出口（除依法须经批准的项目外，凭营业执照依法 自主开展经营活动）。 ...